Johnson & Johnson Stock Rises Tuesday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Johnson & Johnson (JNJ) inched 0.28% higher to $172.39 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.87% to 3,991.73 and the Dow Jones Industrial Average rising 0.17% to 33,592.92. This was the stock's second consecutive day of gains. Johnson & Johnson closed $14.30 short of its 52-week high ($186.69), which the company achieved on April 25th.
The stock outperformed some of its competitors Tuesday, as Roche Holding AG Part. Cert. fell 0.24% to $329.05, Merck & Co. Inc. (MRK) fell 0.75% to $99.60, and Pfizer Inc. (PFE) fell 1.36% to $48.57. Trading volume (9.3 M) eclipsed its 50-day average volume of 7.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 15, 2022.
(END) Dow Jones Newswires
November 15, 2022 16:33 ET (21:33 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.